BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12478160)

  • 1. Rectal squamous cell carcinoma 11 years after brachytherapy for carcinoma of the prostate.
    Yurdakul G; de Reijke TM; Blank LE; Rauws EA
    J Urol; 2003 Jan; 169(1):280. PubMed ID: 12478160
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostatorectal fistula associated with 125iodine seed radiotherapy.
    Mouli K; Sharifi R; Ray P; Baumgartner G; Guinan P
    J Urol; 1983 Feb; 129(2):387-8. PubMed ID: 6834516
    [No Abstract]   [Full Text] [Related]  

  • 3. Rectourethral fistula following LDR brachytherapy.
    Borchers H; Pinkawa M; Donner A; Wolter TP; Pallua N; Eble MJ; Jakse G
    Urol Int; 2009; 82(3):365-6. PubMed ID: 19440030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatorectal fistula 14 years following brachytherapy for prostate cancer.
    Davis JW; Schellhammer PF
    J Urol; 2001 Jan; 165(1):189. PubMed ID: 11125400
    [No Abstract]   [Full Text] [Related]  

  • 5. Rectourethral fistula and massive rectal bleeding from iodine-125 prostate brachytherapy: a case report.
    Cherr GS; Hall C; Pineau BC; Waters GS
    Am Surg; 2001 Feb; 67(2):131-4. PubMed ID: 11243535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Re: Prostatorectal fistula associated with 125iodine seed radiotherapy.
    Schellhammer PF
    J Urol; 1984 Jan; 131(1):126-7. PubMed ID: 6690736
    [No Abstract]   [Full Text] [Related]  

  • 7. Major rectal complications following interstitial implantation of 125iodine for carcinoma of the prostate.
    Jordan GH; Lynch DF; Warden SS; McCraw JD; Hoffman GC; Schellhammer PF
    J Urol; 1985 Dec; 134(6):1212-4. PubMed ID: 4057419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Summary of simultaneous irradiation for prostate cancer.
    Critz FA
    Urology; 2004 Oct; 64(4):633-6. PubMed ID: 15491686
    [No Abstract]   [Full Text] [Related]  

  • 9. Primary squamous cell carcinoma of the prostate after radiation seed implantation for adenocarcinoma.
    Miller VA; Reuter V; Scher HI
    Urology; 1995 Jul; 46(1):111-3. PubMed ID: 7541581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive bladder cancer following 125iodine implants.
    Winters JC; Fuselier HA
    J Urol; 1992 Dec; 148(6):1898-900. PubMed ID: 1433634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late results of combined iodine-125 and external beam radiotherapy in carcinoma of prostate.
    Patel J; Worthen R; Abadir R; Weaver DJ; Weinstein S; Ross G
    Urology; 1990 Jul; 36(1):27-30. PubMed ID: 2368228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Brachyterapy in localized prostate cancer].
    Abascal Junquera JM; Hevia Suarez M; Abascal García JM; Abascal García R; Gonzalez Suárez H; Alonso A; Juan Rijo G; Prada PJ
    Actas Urol Esp; 2007 Jun; 31(6):617-26. PubMed ID: 17896558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probability of late rectal morbidity in 125I prostate brachytherapy.
    Waterman FM; Dicker AP
    Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):342-53. PubMed ID: 12527047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and clinical course of hemorrhagic radiation proctitis after iodine-125 prostate brachytherapy.
    Mishra MV; Shirazi R; Barrett WL
    Clin Genitourin Cancer; 2007 Sep; 5(6):397-400. PubMed ID: 17956713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rectourethral fistula after combination radiotherapy for prostate cancer.
    Marguet C; Raj GV; Brashears JH; Anscher MS; Ludwig K; Mouraviev V; Robertson CN; Polascik TJ
    Urology; 2007 May; 69(5):898-901. PubMed ID: 17482930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer.
    Murray L; Mason J; Henry AM; Hoskin P; Siebert FA; Venselaar J; Bownes P;
    Radiother Oncol; 2016 Aug; 120(2):293-9. PubMed ID: 27370205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rectal adenocarcinoma with rectoprostatic fistula following prostate brachytherapy.
    Moss BF; Peracha AM
    BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30936326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second primary cancers occurring after I-125 brachytherapy as monotherapy for early prostate cancer.
    Musunuru H; Mason M; Murray L; Al-Qaisieh B; Bownes P; Smith J; Franks K; Carey B; Bottomley D; Henry AM
    Clin Oncol (R Coll Radiol); 2014 Apr; 26(4):210-5. PubMed ID: 24507938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiation-induced prostatic sarcoma: a case report.
    Scully JM; Uno JM; McIntyre M; Mosely S
    J Urol; 1990 Sep; 144(3):746-8. PubMed ID: 2388344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rectal morbidity after permanent prostate brachytherapy with dose escalation to biologic target volumes identified by SPECT/CT fusion.
    Ellis RJ; Zhou H; Kaminsky DA; Fu P; Kim EY; Sodee DB; Colussi V; Spirnak JP; Whalen CC; Resnick MI
    Brachytherapy; 2007; 6(2):149-56. PubMed ID: 17434109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.